Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors (Q37222786)
Jump to navigation
Jump to search
scientific article published on July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors |
scientific article published on July 2016 |
Statements
1 reference
Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors (English)
1 reference
Hidenori Mizugaki
Haruyasu Murakami
Hirotsugu Kenmotsu
Yoshimasa Ishida
Tomohisa Kawakami
1 July 2016
1 reference
1 reference
1 reference
1 reference